Related Experiment Video
Updated: Jul 15, 2025

Burn Injury-Induced Pain and Depression-Like Behavior in Mice
Published on: September 29, 2021
Antidepressant-induced burning mouth syndrome: A case report
Alaa Alesa1, Wid Kattan2, Abdulhadi Albadri1
1College of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.
Abstract:
Burning mouth syndrome is a chronic condition characterized by oral pain in the absence of intraoral clinical signs. The pathogenesis and etiology of burning mouth syndrome are not fully understood. Both men and women of all ages are at risk of developing this syndrome, but women are at an even higher risk. The management of burning mouth syndrome usually consists of the use of antidepressants. In this case report, we present a case of a 75-year-old lady who presented to the psychiatric clinic for management of her depressive symptoms. She was prescribed escitalopram and her dose was later increased. She then started experiencing a burning sensation in her mouth. She was seen by dental, medical, and psychological specialties regarding her symptoms. After careful historical and clinical evaluation, she was finally diagnosed with antidepressant-induced burning mouth syndrome. Antidepressant-induced burning mouth syndrome is a rare but very important condition to recognize. It has a huge effect on patients' quality of life. The management of patients with antidepressant-induced burning mouth syndrome needs the involvement of a multidisciplinary team. Further high-quality studies are needed to help healthcare professionals better approach such patients.
More Related Videos
Related Concept Videos
Antidepressant Drugs: MAOIs and Other Agents
Antidepressant Drugs: Overview
Taste Buds and Receptors
Gastroesophageal Reflux Disease II: Clinical Features and Management
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs

